Overview
Joel Mindel is an Ophthalmologist practicing medicine in New York, New York.
His clinical expertise encompasses Oculomotor Apraxia Cogan Type, Amblyopia, Optic Atrophy Type 1, and Optic Nerve Atrophy.
He is actively involved in clinical research, co-authoring 3 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1 Gustave L Levy Pl, New York, NY 10029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rockefeller Outpatient Pavilion
Jasmine Francis is an Ophthalmologist practicing medicine in New York, New York. Dr. Francis is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.
Vitreous Retina Macula Consultants Of New York
Richard Spaide is an Ophthalmologist practicing medicine in New York, New York. Dr. Spaide is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.
Memorial Sloan Kettering Cancer Center
David Abramson is an Ophthalmologist practicing medicine in New York, New York. Dr. Abramson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.
Vitreous Retina Macula Consultants Of New York
Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Gregory J. Pamel MD PC
Anastasios Kanellopoulos is an Ophthalmologist practicing medicine in New York, New York. Dr. Kanellopoulos is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Keratoconus, Astigmatism, Nearsightedness, Cataract Removal, and Corneal Transplant.
ColumbiaDoctors - Third Avenue
Dr. Jeffrey M. Liebmann is a Professor of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center.Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection. Dr. Liebmann is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Liebmann is board certified in Ophthalmology. Dr. Liebmann is currently accepting new patients.
Frequently Asked Questions about Dr. Joel S. Mindel
How do I make an appointment with Dr. Joel S. Mindel?
You can book an appointment with Dr. Joel S. Mindel by calling their office at 212-241-8800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Joel S. Mindel a top-rated expert for Oculomotor Apraxia Cogan Type?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joel S. Mindel is classified as an Experienced expert for Oculomotor Apraxia Cogan Type, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Joel S. Mindel specialize in?
While Dr. Joel S. Mindel is a Ophthalmology, they have specific expertise in Oculomotor Apraxia Cogan Type, Amblyopia, and Optic Atrophy Type 1. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Joel S. Mindel participate in research or clinical trials?
Yes. Dr. Joel S. Mindel has published 3 articles and abstracts on conditions like Oculomotor Apraxia Cogan Type. You can view a list of Dr. Joel S. Mindel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AmblyopiaDr. Mindel isExperienced. Learn about Amblyopia.
- Oculomotor Apraxia Cogan TypeDr. Mindel isExperienced. Learn about Oculomotor Apraxia Cogan Type.
- Optic Atrophy Type 1Dr. Mindel isExperienced. Learn about Optic Atrophy Type 1.
- Optic Nerve AtrophyDr. Mindel isExperienced. Learn about Optic Nerve Atrophy.
- StrabismusDr. Mindel isExperienced. Learn about Strabismus.

